Author name: camms

Risk Management: 10 Reasons to Switch from Spreadsheets to Software

If your risk management team is still using spreadsheets, then it might be time to digitise & modernise your processes. Spreadsheets create silos and lack data governance – resulting in poor quality risk data, and manual inputting & reporting tasks. Check out our infographic where we do a direct comparison between spreadsheets vs software for

Risk Management: 10 Reasons to Switch from Spreadsheets to Software Read More »

Beyond the Numbers: Telling Your ESG Story to Stakeholders

Demonstrating progress against your ESG initiatives – with clear evidence to ‘back-up’ the claims – builds trust in your organisation, supports your overall corporate reputation, and enhances your relationship with your employees and customers.  So how do you tell your ESG story to stakeholders? To be able to tell a credible ESG story you first

Beyond the Numbers: Telling Your ESG Story to Stakeholders Read More »

Eliminate Legacy Systems & Save Money through Application Rationalisation

Most IT leaders today are stuck addressing technical debt in the form of outdated or redundant legacy systems and applications. In a business landscape characterised by uncertain economic conditions where profit is never a guarantee, each day spent paying for unnecessary or duplicate systems is revenue lost. Which is why there has never been a

Eliminate Legacy Systems & Save Money through Application Rationalisation Read More »

Managing Risk in the Pharmaceutical & Life Sciences Sector

The pharmaceutical & Life Sciences industry has always been associated with groundbreaking trials, discoveries, and innovation. However, this experimental work also exposes pharma companies to an exorbitant amount of risk. High risk areas include clinical-trials, product design & production, drug approval, product quality, and adherence to global commercial practices. These risks must be carefully monitored &

Managing Risk in the Pharmaceutical & Life Sciences Sector Read More »

Managing Compliance in the Pharmaceutical & Life Sciences Sector

For years now, the pharmaceutical & Life Sciences industry has had to contend with a less than stellar reputation mainly due to unethical business practices and high drug prices. The pharmaceutical industry is among the most heavily regulated in the world. It is subject to intense scrutiny and with good reason: medicines & treatments can

Managing Compliance in the Pharmaceutical & Life Sciences Sector Read More »

Scroll to Top